Petco Health & Wellness WOOF
- Market cap
- $794.3M
- PE
- 24.5×
- 5y median 30.9×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.1×
- EV/EBIT
- 14.8×
- Revenue, 12 months
- $6B
- −1% on a year ago
- Net margin
- 0.5%
- Free cash flow yield
- 29.9%
Petco Health & Wellness trades at 24.5× trailing earnings, cheaper than 76% of the last ten years. Revenue was $6B over the last twelve months, down 1% on a year earlier with a 1% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.5B−1% | $1.7B+6% | $1.5B−2% | $1.5B−1% | $1.5B+1% | $1.6B−7% | $1.5B−2% | $1.5B−2% | $1.5B−3% | $1.5B−2% | $1.5B+0% | $1.5B+0% | |
| Cost of revenue | $944.2M+5% | $1.1B+12% | $950.5M−0% | $943M+1% | $935.7M−1% | $962.9M−10% | $923.4M−3% | $903.2M−4% | $895.4M−4% | $934.4M−3% | $922.3M−0% | $898.1M−1% |
| Gross profit | $550M−8% | $606.3M−3% | $578.7M−4% | $580.7M−2% | $575.8M+5% | $589.3M−3% | $570M−2% | $585.3M+1% | $569M−1% | $580.8M−1% | $574.4M+1% | $591.1M+1% |
| SG&A | $559.6M+2% | $606.2M+10% | $595.4M+3% | $578.3M+2% | $571.8M+2% | $571.9M−6% | $553.6M−7% | $542.3M−6% | $539.8M−6% | $548.9M−4% | $549.8M−1% | $543.3M+0% |
| −$1.2B | $166K−100% | −$16.8M | $2.5M−90% | $4M | $17.4M+10375% | $16.4M | $43M+1643% | $29.2M+634% | $31.9M+83% | $24.6M+51% | $47.8M+11% | |
| Interest expense | $36.6M+34% | $39.7M+21% | $36.8M−1% | $36.8M−2% | $35.8M−2% | $34.1M−14% | $33.5M−9% | $33.3M−10% | $32.8M−8% | $31.6M−7% | $32.8M−2% | $32.6M−2% |
| Pre-tax income | −$1.3B | −$39.2M | −$55.8M+826% | −$33.7M+201% | −$22M−98% | −$16.4M−58% | −$15.8M−72% | $10.6M | −$1.8M−92% | $1.9M | −$18.5M+17% | $17.7M+67% |
| −$22.9M | −$10.4M | −$4.5M+344% | −$4.7M | −$857K−96% | $2.5M | $495K | $746K | −$6.3M+632% | $11.3M+351% | $2.2M+344% | −$15.7M | |
| Net income | −$1.2B | −$22.6M | −$46.5M+2357% | −$24.8M+70% | −$16.7M−99% | −$13.8M−39% | −$11.7M−75% | $14M | $9.3M | −$2.6M−81% | −$15.1M+30% | $38.7M+177% |
| −$4.63 | −$0.08 | −$0.17+1600% | −$0.09+80% | −$0.06−99% | −$0.05−38% | −$0.04−77% | $0.05 | $0.03 | −$0.01−80% | −$0.05+25% | $0.13+160% | |
| 267.9M+1% | 268.6M+1% | 269.8M+1% | 273.1M+2% | 274.5M+3% | 276.3M+3% | 277.5M+3% | 285.7M+5% | 288.2M+5% | 281.2M+2% | 283.7M+2% | 290.5M+2% |
EPS, diluted: 6 periods, Q4 FY20 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 4 periods, Q4 FY20 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY21 and Q4 FY22: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Specialty Retail nearest Petco Health & Wellness' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| WOOFPetco Health & Wellness | $794.3M | 24.5× | 30.9× | 0.1× | −1% | 0.5% | |
| WINAWinmark | $995.5M | 25.0× | 24.6× | 10.8× | +9% | 45.1% | |
| HZOMarinemax | $1.2B | 376× | 10.3× | 0.5× | −5% | 0.2% | |
| SPHSuburban Propane Partners | $1.2B | 9.1× | 13.1× | 0.8× | −2% | 9.4% | |
| BNEDBarnes & Noble Education | $470.4M | 21.2× | 25.8× | 0.3× | +5% | 1.3% | |
| SVVSavers Value Village | $1.4B | 58.6× | 53.6× | 0.8× | +10% | 1.4% | |
| SGUStar | $431.5M | 4.9× | 9.6× | 0.2× | +8% | 4.6% | |
| RVLVRevolve | $1.6B | 22.0× | 43.3× | 1.2× | +11% | 5.5% | |
| SBHSally Beauty | $1.6B | 9.1× | 8.3× | 0.4× | +1% | 5.2% | |
| ARHSArhaus | $1.7B | 23.4× | 17.5× | 1.2× | +5% | 4.9% | |
| EZPWEzcorp | $1.8B | 14.6× | 17.6× | 1.1× | +29% | 10.0% | |
| Peer median | $1.3B | 21.6× | 17.5× | 0.8× | +7% | 5.0% |
More on Petco Health & Wellness
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #5of 259Consumer cyclical stocks with the highest free cash flow yield
- #2of 45Specialty retail stocks with the highest free cash flow yield
- #7of 61Specialty retail stocks with the lowest price to sales ratio
Its groups
About
- Industry
- Specialty Retail
- Sector
- Consumer Cyclical
Valuation data, not investment advice. Prices as of .